Zhejiang Ausun Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 467.73 million compared to CNY 381.35 million a year ago. Revenue was CNY 468.72 million compared to CNY 381.36 million a year ago.

Net income was CNY 160.2 million compared to CNY 123.02 million a year ago. Basic earnings per share from continuing operations was CNY 0.27 compared to CNY 0.22 a year ago. Diluted earnings per share from continuing operations was CNY 0.27 compared to CNY 0.22 a year ago.